March 2026: Updates to Oxygen Concentrator and Condom Standards in Health Care

In March 2026, important new international standards were released for the health care technology sector, aiming to enhance both patient safety and product quality. This fifth and final update for the month highlights two crucial standards: updated safety and performance requirements for oxygen concentrators (FprEN ISO 80601-2-69) and the revised global specification for natural rubber latex male condoms (ISO 4074:2026). These updates deliver robust frameworks for manufacturers, healthcare providers, and supply chain managers to ensure the highest levels of safety and efficacy in medical device usage.

Overview / Introduction

The health care technology sector relies heavily on rigorous, internationally aligned standards to ensure devices and consumables are safe, reliable, and effective. Standards play a pivotal role in supporting clinical efficiency, driving product innovation, and minimizing risk in both patient and professional settings. This article unpacks the latest updates for March 2026, offering industry professionals, compliance teams, product engineers, and procurement leaders insight into:

• The technical and operational impact of these new or revised standards
• Direct pathways for compliance and best practice implementation
• Key highlights to help organizations adapt efficiently and remain at the forefront of health care quality and patient safety

Detailed Standards Coverage

FprEN ISO 80601-2-69 – Safety and Performance of Oxygen Concentrator Equipment

Medical electrical equipment – Part 2-69: Particular requirements for the basic safety and essential performance of oxygen concentrator equipment (ISO/FDIS 80601-2-69:2025)

FprEN ISO 80601-2-69 defines safety and essential performance specifications for oxygen concentrators—devices that enrich the oxygen content of air for therapeutic use. This standard is particularly pertinent as the demand for homecare and portable medical equipment rises globally.

Scope and Application

The standard covers both transit-operable (portable) and non-transit-operable oxygen concentrators, as well as concentrators integrated within broader medical systems or used with specialized accessories such as humidifiers and oxygen conserving equipment. These devices are often used in:

• Home health care
• Emergency vehicles
• Public transportation
• Professional healthcare facilities
• Commercial aircraft

Key Requirements and Specifications

• Basic Safety: Adherence to core electrical and mechanical safety ensures device and user protection.
• Essential Performance: Criteria for oxygen concentration output, flow rates, alarm systems, and usability (including in transit and non-clinical settings).
• Accessories Impact: Any mask, tubing, humidifier, or oxygen conserving equipment must not compromise primary device safety or functionality.
• Testing: Stringent methods drawn from collateral standards, including rigorous tests for biocompatibility, electromagnetic compatibility, labelling, and alarms.
• Cybersecurity: Newly added guidance addresses risks related to connectivity and patient data integrity.

Who Should Comply?

• Oxygen concentrator manufacturers and OEM partners
• Accessory suppliers (masks, tubing, humidifiers, etc.)
• Health care providers procuring such equipment
• Regulatory affairs and quality assurance professionals
• Homecare service providers and transportation authorities using medical oxygen systems

Practical Implications

• Product Development: Engineering teams must harmonize with a broad array of updated normative references (e.g., ISO 20417, IEC 60601 series, ISO 18562-1 for biocompatibility).
• Product Marking and Labelling: New marking requirements for gas intake ports, MR compatibility, and other attributes must be reflected on labeling and IFUs.
• Risk Management: Enhanced guidance for accessories, cybersecurity, and usability means all system components must be risk-assessed as a whole.
• Transition: Organizations already certified to previous versions must map updates and demonstrate compliance with new requirements, such as uncertainty of measurement and expanded connector specifications.

Notable Changes from Previous Editions

• Updated references and harmonization with recent international standards
• Expanded requirements for uncertainty of measurement
• Marking and labelling updates, including MR compatibility and gas intake port identification
• Added cybersecurity considerations
• Enhanced guidance on processing the enclosure and connector requirements

Key highlights:

• Home and portable concentrator coverage, plus integration with transport and complex systems
• Comprehensive accessory assessment for risk and performance
• Harmonized, up-to-date safety, performance, and labelling requirements

Access the full standard:View FprEN ISO 80601-2-69 on iTeh Standards

ISO 4074:2026 – Requirements and Test Methods for Natural Rubber Latex Male Condoms

Natural rubber latex male condoms — Requirements and test methods

ISO 4074:2026 represents the authoritative global benchmark for quality, safety, and performance of natural rubber latex male condoms. As a critical medical device, up-to-date condom standards are essential for public health, disease prevention, and patient trust.

Scope and Application

ISO 4074:2026 specifies comprehensive criteria for:

• Dimensions, strength, and physical quality (length, width, thickness, bead integrity)
• Package integrity and labeling
• Biocompatibility and microbial contamination
• Claims, quality verification, and shelf life

This standard does not cover medicinal substances applied to the condom, which are regulated under other national or regional health protocols.

Key Requirements and Specifications

• Lot Quality and Sampling: Adopts ISO 2859-1 for inspection, with clear AQL thresholds for properties like burst pressure and freedom from holes.
• Physical and Chemical Tests: Methodologies for measuring bursting volume/pressure (Annex H), water leak detection, and dimensions.
• Stability and Shelf Life: Mandatory real-time and accelerated aging studies, with a maximum shelf life claim of 5 years.
• Biocompatibility: All materials and applied substances must pass risk assessment per ISO 10993-1 and ISO 14971. Lab testing should comply with ISO/IEC 17025.
• Microbial Quality: Manufacturers must monitor absence of specific pathogens and maintain defined bioburden controls based on best practices (Annex G).
• Packaging and Labelling: Each condom must be in an individual, light-obscuring container with traceable lot and expiry details. Consumer packages must display essential product details, manufacturer contact data, and expiry in a standardized format.

Who Should Comply?

• Condom manufacturers and contract packagers
• Procurement and supply chain managers in public health
• Regulatory and third-party test or certification laboratories
• Distributors and brands marketing condoms worldwide
• Healthcare NGOs and agencies overseeing sexual health programs

Practical Implications

• Sampling and Quality Assurance: Organizations must adopt robust lot tracking, test plans, and AQL-compliant controls.
• Design and Documentation: Documentation now requires clear validation of any product change (formulation, packaging, site) with risk assessments and updated stability data.
• Labelling Compliance: Packaging must reflect updated symbol use and traceability per ISO 15223-1 and ISO 20417.
• Transition Planning: Manufacturers should prepare for a transition period, ensuring new procedures and tests are in place before implementation deadlines.

Notable Changes from Previous Editions

• Addition of coverage for all condom sizes (including those outside historical nominal ranges)
• Amendments to sampling and testing protocols for new and modified designs
• Updated procedures for lubricant removal, microbial testing, and accelerated shelf life assessments
• New requirements for verification and validation of hole testing methods
• Enhanced guidance on packaging, including the option for dry vacuum integrity testing

Key highlights:

• Broadens scope to all condom dimensions and configurations
• Updated requirements for burst tests, shelf life, and microbial assurance
• Fresh packaging and labeling mandates for improved traceability

Access the full standard:View ISO 4074:2026 on iTeh Standards

Industry Impact & Compliance

The introduction of these March 2026 health care technology standards will directly impact sourcing, manufacturing, and regulatory compliance throughout the sector.

• For device manufacturers: Early integration of new requirements into design and process validation is essential. Assess your product lifecycles, labeling templates, and accessory qualification now to avoid market access delays.
• Purchasing and quality managers: Review supplier contracts to ensure components, accessories, and finished goods comply with updated AQL, shelf life, and packaging requirements. Demand updated conformity certification from all supply-chain partners.
• Healthcare providers and NGO agencies: Stay alert to compliance markers—especially for consumer-facing goods like condoms—and verify manufacturers’ test and traceability documentation.

Benefits:

• Elevates patient and user safety
• Supports market access and global supply chain efficiency
• Boosts trust with end users and regulators

Risks of non-compliance:

• Regulatory penalties, market recalls, or restricted product access
• Increased liability for patient safety incidents
• Damaged public trust and brand reputation

Implementation Timelines: Organizations should consult the standard documents for transition periods and compliance deadlines, allowing buffer time for internal validation and third-party assessment where necessary.

Technical Insights

Cross-cutting Technical Themes:

• Biocompatibility: Both standards demand rigorous review based on current ISO 10993 guidance and risk management throughout the product lifecycle.
• Traceability and Lot Control: Lot number systems, traceable labeling, and batch records are essential for both oxygen concentrator components and condom collections.
• Packaging Integrity: From gas pathway protection (oxygen concentrators) to light-opaque, tamper-resistant packs (condoms), the focus is on minimizing external contamination and ensuring user safety through the device’s shelf life.
• Testing and Certification: Laboratories should ensure staff are trained in updated methods (particularly new or revised conformance and stability assays) and equipment is maintained/calibrated to the latest specifications.
• Cybersecurity: For electrical medical equipment, updated requirements now expect proactive assessment and mitigation of digital threats.

Implementation Best Practices:

1. Conduct a comprehensive gap analysis between previous and new standard requirements
2. Train R&D, quality, and production teams on technical and documentation changes
3. Revalidate sample and test plans, especially for burst, microbial, and package integrity testing
4. Engage with notified bodies and certification partners early
5. Update documentation and risk management files (e.g., to meet ISO 14971 and ISO 13485 standards)

Conclusion / Next Steps

These March 2026 standard updates reinforce the central place of robust, harmonized requirements in health care product safety and performance. Whether you manufacture oxygen concentrators, supply latex condoms, or manage health technology procurement, these standards will inform critical decisions for product development, purchasing, and compliance in the months and years ahead.

Key recommendations:

• Download and study the full text of the referenced standards
• Map the requirements to your specific organizational context
• Develop and implement a documented transition plan
• Monitor communications from standards bodies for further updates
• Visit iTeh Standards for up-to-date access, implementation resources, and expert guidance

Stay tuned to further updates by subscribing to standards notifications and joining sector-specific forums hosted by iTeh Standards to ensure ongoing awareness of essential compliance developments.